JointFlex
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer of pain reliever. The product line utilizes the Fusome skin delivery technology and contains camphor plus Glucosamine and Chondroitin Sulfate for skin conditioning. This technology enables the beneficial ingredients to be delivered quickly and safely to the skin.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- 7 East Frederick Place
- Suite 100
- Cedar knolls, NJ 07927
- United States
+1 (973) 000-0000
JointFlex Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore JointFlex‘s full profile, request access.
Request full access to PitchBook